Alyeska Investment Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Alyeska Investment Group's GILD Position: Q3 2025 in Review
Alyeska Investment Group sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 44,661 shares — an estimated $4.95M sold.
Alyeska Investment Group first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $101M in Q1 2016. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Alyeska Investment Group reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Alyeska Investment Group sold 44,661 Gilead Sciences shares in Q3 2025, an estimated $4.95M.
- Alyeska Investment Group first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
- Alyeska Investment Group's Gilead Sciences position peaked at $101M in Q1 2016.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.